Page thématique

Veterinary medicine - ANMV

The French Agency for Veterinary Medicinal Products (ANMV), within ANSES, is the Competent Authority in France for risk assessment and management with regard to veterinary medicinal products.

In this capacity, the Government was keen for the ANMV to strive for constant improvement of its services with a view to protecting public health as well as the health and welfare of animals.

To this end, the ANMV must enforce the current applicable legal provisions in an independent, competent and impartial manner. Click here to find out more about the Agency’s history.

The ANMV is located in Javené, near Fougères (Ille-et-Vilaine) and has 80 staff members, mainly specialised scientists.

 

 

 

 

Declaring an adverse effect that may be due to a veterinary medicinal product (in French)

Sector professionals

List of veterinary pharmaceutical manufacturers and wholesalers (in French)

 

Marketing authorization (AMM) no./National Working Group (GTIN) code correspondence table (in French)

News

Franck Fourès appointed Director of the French Agency for Veterinary Medicinal Products
22/09/2022

Franck Fourès appointed Director of the French Agency for Veterinary Medicinal Products

Franck Fourès was appointed Director of the French Agency for Veterinary Medicinal Products, part of ANSES, by order of the Ministers of Agriculture and Health, on 29 July 2022. He will take up his new position on 1 November 2022.
Good practices in the use of veterinary medicines for pets
28/07/2022

Good practices in the use of veterinary medicines for pets

Every year, many accidents are reported following the incorrect storage and use of veterinary medicines. In France, over 400 people were victims of this type of accident in 2020. While most reported cases are minor, more serious cases of poisoning can occur, particularly in young children.
ANSM et ANSES, together in a "one health" approach
25/07/2022
News

ANSM et ANSES, together in a "one health" approach

Joint interview with Jean-Pierre Orand, Director of the French Agency for Veterinary Medicinal Products (ANMV) within ANSES, and Caroline Semaille, Deputy Director General in charge of Operations at the French Health Products Safety Agency (ANSM).
Publication of the 2021 Activity Report on Veterinary Medicinal Products
12/07/2022
News

Publication of the 2021 Activity Report on Veterinary Medicinal Products

This report takes stock of the activities of the French agency for veterinary medicinal products in 2021 with the highlights of the past year. It proposes a review of all the Agency’s actions in the field of veterinary medicinal products and details in particular the changes brought about by the entry into force of the Regulation on veterinary medicinal products. View the 2021 report for veterinary medicinal products (PDF)
To limit environmental exposure to antibiotics in veterinary medicine treatments
22/06/2022
News

To limit environmental exposure to antibiotics in veterinary medicine treatments

Many antibiotics are used in both humans and animals. As part of the One Health approach, the Veterinary Medicines Monitoring Committee, attached to the Director of Anses-ANMV, has just published an article on the impact of antibiotics on the environment.
Storage of veterinary medicines and recommendations during heatwaves
21/06/2022
News

Storage of veterinary medicines and recommendations during heatwaves

Veterinary medicine quality is vital and must be ensured throughout the pharmaceutical chain, from design until use. Each participant in the chain has an influence on one or more parameters and needs to take precautions to guarantee and maintain veterinary medicine quality. During the summer, especially in cases of high heat, the storage of veterinary medicinal products may be affected; beyond 40 °C, there are risks of irreversible degradation (quality, effectiveness) or even toxicity (formation of degradation products).
Overview of the European conference on the use of plants in veterinary medicine
20/05/2022
News

Overview of the European conference on the use of plants in veterinary medicine

The conference was organised in several sessions. In the first session, the context of the use of plants in veterinary medicine in the European Union was presented and the various stakeholders (farmers, veterinarians and pharmaceutical industries) were able to share their expectations and problems with the use of veterinary herbal medicines. Secondly, two experts from the Human Committee on Herbal Medicinal Products presented a feedback on the problems encountered in the authorisation of herbal medicinal products for human use compared to conventional chemical medicinal products. Then, the Anses-ANMV gave a feedback on the work carried out by France, in particular on the referral 2014-SA-0083 . Finally, these sessions continued with the presentation of the perspectives at European level by the EMA and the European Commission and the sharing of the views of the participants. Conference overview
Birth control pills for female cats and dogs must be prescribed by a veterinarian
19/05/2022
News

Birth control pills for female cats and dogs must be prescribed by a veterinarian

Birth control pills for pets can have serious side effects. They should therefore only be dispensed on prescription by a veterinarian and used in accordance with a number of recommendations.
PFUE — European Conference on the Use of Plants in Veterinary Medicine
08/04/2022
News

PFUE — European Conference on the Use of Plants in Veterinary Medicine

As part of the French Presidency of the Council of the European Union (PFUE), the French agency for veterinary medicinal products (Anses-ANMV) organised a European conference on the use of plants in veterinary medicine on 29 March. The conference, intended for the competent European authorities, was held remotely and attended 54 participants from outside the Anses.
Meeting of Heads of Agency (HMA) from 4 to 6 May 2022
12/05/2022
News

Meeting of Heads of Agency (HMA) from 4 to 6 May 2022

The French agency for veterinary medicinal products (Anses-ANMV) organised with Ansm (French agency for human medicines) the second meeting of Heads of Agency (HMA) from 4 to 6 May. The meeting was held at the Palais du Grand Large in Saint Malo with 90 participants from the competent European authorities, the European Commission and the European Medicines Agency (EMA). On the first day, a meeting was organised with stakeholders: representatives of the veterinary medicine industry, veterinarians, farmers and the veterinary diagnosis industry. Among other things, the meeting provided an opportunity to discuss the implementation of the Veterinary Regulations. On May 5th and 6th, the heads of medicines agencies met for a day and a half. At the veterinary session, the European strategy HMA-EMA 2021-2025 on “Big Data” was adopted as well as the Action Plan of the Network of Agencies’ 2025 Strategy. Part of this event was dedicated to medical devices for human use.
A new process for monitoring adverse reactions to veterinary medicines
04/05/2022
News

A new process for monitoring adverse reactions to veterinary medicines

A new EU-wide pharmacovigilance scheme has been launched with the new EU Regulation on veterinary medicinal products. It aims to manage the adverse effects of veterinary medicines and applies to all medicines authorised in at least one European Union country. We put three questions on this new process to Sylviane Laurentie, deputy director of the French Agency for Veterinary Medicinal Products, responsible for inspection, surveillance and pharmacovigilance.
Three new databases for greater transparency on veterinary medicinal products in Europe
07/03/2022
News

Three new databases for greater transparency on veterinary medicinal products in Europe

The new Regulation (EU) No 2019/6 on veterinary medicinal products provides for the creation of three databases, designed to improve access to and sharing of information on these products. Here is an overview of their objectives.

Decryption

Head lice: never use animal treatments on children
30/08/2022

Head lice: never use animal treatments on children

Every year, cases of use of antiparasitic products intended for pets to treat head lice in children are reported. The Agency emphasises that antiparasitic treatments, insecticides or acaricides for pets should never be used on human beings, especially children.
Antimicrobial resistance: a major issue for animals and humans
08/01/2021

Antimicrobial resistance: a major issue for animals and humans

Antimicrobial resistance is a major issue for both human and animal health. The emergence and spread of antibiotic-resistant bacterial strains call into question the efficacy of these treatments. Preserving the efficacy of antibiotics is therefore a genuine public health challenge, requiring an integrated approach according to the One Health concept covering both humans and animals.
The proper use of ectoparasiticides in domestic animals
13/04/2018

The proper use of ectoparasiticides in domestic animals

External parasites can cause serious illnesses in animals, or even lead to diseases that are transmissible to humans. To control and/or prevent these diseases, a range of veterinary medicinal products are available.
ANSES: a brief outline
30/07/2015

ANSES: a brief outline

Created on 1 July 2010, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) is an independent scientific body which performs its risk assessment, reference and research activities in the fields of food safety and animal and plant health. Its core activity is the assessment of health risks in order to enable the public authorities to make informed decisions and in so doing to help ensure the health and safety of of the population both in its working and consumer activities
Head lice treatments
18/05/2015

Head lice treatments

Antiparasitics, insecticides and anti-mite treatments intended for pets should never be used on humans, especially children. Veterinary medicinal products obtain marketing authorisation (MA) prior to marketing based on a risks vs benefits assessment for the animal they are to be used on. If the risks for humans have been identified and evaluated, it is only with regard to the risks for individuals who handle or administer the products.
ANSES laboratories
15/02/2013

ANSES laboratories

ANSES has a network of nine reference and research laboratories located throughout France, close to industry. These laboratories operate in three main areas: animal health and welfare, food safety (chemical and microbiological) and plant health. They are internationally recognised in their respective fields of expertise: epidemiology, microbiology and antimicrobial resistance, toxins and physico-chemical contaminants. Thanks to their work in providing expertise, epidemiological monitoring, alerts and scientific and technical assistance, they play a vital role in understanding various threats and in collecting data from the network of accredited laboratories.

Publications